EEF1A2 and breast carcinoma: Several sTn-specific scFvs were adapted from B72.3, the first mAb developed against sTn 142, 143 on tumour-associated glycoprotein 72 (TAG-72) 144 using enriched membrane fractions of a breast carcinoma biopsy as immunogen 145.